Evidence map›Paper›PMID 29272387›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2018

Contribution of Maternal Antiretroviral Therapy and Breastfeeding to 24-Month Survival in Human Immunodeficiency Virus-Exposed Uninfected Children: An Individual Pooled Analysis of African and Asian Studies.

Shino Arikawa, Nigel Rollins, Gonzague Jourdain, Jean Humphrey, Athena P Kourtis, Irving Hoffman, Max Essex, Tim Farley, Hoosen M Coovadia, Glenda Gray and 15 more

Open access · hybridAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Short-term outcomes of HIV-exposed and HIV-unexposed preterm, very low birthweight neonates: a longitudinal, hospital-based study.Journal of perinatology : official journal of the California Perinatal Association · 2020
    Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 19 institutions in 7 countries.

Shino ArikawaUniversity of Bordeaux, Inserm, Bordeaux Population Health Research Center, Team IDLIC, France.
Nigel RollinsDepartment of Maternal, Newborn, Child and Adolescent Health, World Health Organization, Geneva, Switzerland.
Gonzague JourdainInstitut de recherche pour le développement UMI 174-PHPT, Marseille, France.
Jean HumphreyDepartment of International Health, Center for Global Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland.
Athena P KourtisWomen's Health and Fertility Branch, Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention.
Irving HoffmanDivision of Infectious Diseases, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill.
Max EssexDepartment of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Tim FarleySigma3 Services SÀRL, Nyon, Switzerland.
Hoosen M CoovadiaMaternal Adolescent and Child Health, University of the Witwatersrand, Johannesburg.
Glenda GraySouth African Medical Research Council, Cape Town.
Louise KuhnGertrude H. Sergievsky Center, College of Physicians and Surgeons, and Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York.
Roger ShapiroDepartment of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Valériane LeroyInserm, Centre de recherche Inserm U1027, Université Paul Sabatier Toulouse 3, France.
Robert C BollingerCenter for Clinical Global Health Education, Johns Hopkins University, Baltimore, Maryland.
Carolyne Onyango-MakumbiMakerere University-Johns Hopkins University Research Collaboration/MU-JHU CARE LTD, Kampala, Uganda.
Shahin LockmanDepartment of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Carina MarquezDivision of HIV, Infectious Diseases and Global Medicine, University of California San Francisco, and Zuckerberg San Francisco General Hospital.
Tanya DohertySouth African Medical Research Council, Cape Town.
François DabisUniversity of Bordeaux, Inserm, Bordeaux Population Health Research Center, Team IDLIC, France.
Laurent MandelbrotUniversity Paris-Diderot, Assitance Publique Hôpitaux de Paris.
Sophie Le CoeurInstitut de recherche pour le développement UMI 174-PHPT, Marseille, France.
Matthieu RollandUniversity of Bordeaux, Inserm, Bordeaux Population Health Research Center, Team IDLIC, France.
Pierre JolyUniversity of Bordeaux, Inserm, Bordeaux Population Health Research Center, Team Biostatistics, France.
Marie-Louise NewellInstitute for Developmental Science and Global Health Research Institute, Faculty of Medicine, University of Southampton, United Kingdom.
Renaud BecquetUniversity of Bordeaux, Inserm, Bordeaux Population Health Research Center, Team IDLIC, France.
Harvard University · USUniversité de Bordeaux · FRInserm · FRJohns Hopkins University · USChiang Mai University · THColumbia University · USDélégation Paris 7 · FREmory University · USInstitut de Recherche pour le Développement · FRMUJHU Research Collaboration · UGOffice of Infectious Diseases · USPerinatal HIV Research Unit · ZASigma-Tau (Switzerland) · CHSouth African Medical Research Council · ZAUniversité Toulouse III - Paul Sabatier · FRUniversity of California, San Francisco · USUniversity of Southampton · GBUniversity of the Witwatersrand · ZAWorld Health Organization · CH

Funding

The immunologic consequences of prenatal exposure to malariaP01HD059454 · NICHD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HAVLIR, DIANE V · 2008 to 2017
$22.6M
Training in HIV Translational ResearchT32AI060530 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Diane V Havlir · 2005 to 2026
$6.4M
Childhood Tuberculosis Infection Among School-Age Children in Rural UgandaK23AI118592 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MARQUEZ, CARINA · 2015 to 2019
$946k
NIAID NIH HHS K23 AI118592NIAID NIH HHS T32 AI060530NICHD NIH HHS P01 HD059454World Health Organization 001
6 · The paper itself

Abstract

Background: Human immunodeficiency virus (HIV)-infected pregnant women increasingly receive antiretroviral therapy (ART) to prevent mother-to-child transmission (PMTCT). Studies suggest HIV-exposed uninfected (HEU) children face higher mortality than HIV-unexposed children, but most evidence relates to the pre-ART era, breastfeeding of limited duration, and considerable maternal mortality. Maternal ART and prolonged breastfeeding while on ART may improve survival, although this has not been reliably quantified. Methods: Individual data on 19 219 HEU children from 21 PMTCT trials/cohorts undertaken from 1995 to 2015 in Africa and Asia were pooled to estimate the association between 24-month mortality and maternal/infant factors, using random-effects Cox proportional hazards models. Adjusted attributable fractions of risks computed using the predict function in the R package "frailtypack" were used to estimate the relative contribution of risk factors to overall mortality. Results: Cumulative incidence of death was 5.5% (95% confidence interval, 5.1-5.9) by age 24 months. Low birth weight (LBW <2500 g, adjusted hazard ratio (aHR, 2.9), no breastfeeding (aHR, 2.5), and maternal death (aHR, 11.1) were significantly associated with increased mortality. Maternal ART (aHR, 0.5) was significantly associated with lower mortality. At the population level, LBW accounted for 16.2% of 24-month mortality, never breastfeeding for 10.8%, mother not receiving ART for 45.6%, and maternal death for 4.3%; combined, these factors explained 63.6% of deaths by age 24 months. Conclusions: Survival of HEU children could be substantially improved if public health practices provided all HIV-infected mothers with ART and supported optimal infant feeding and care for LBW neonates.

Indexed as

Breast FeedingAdolescentAdultAfricaAnti-HIV AgentsAsiaChild MortalityChild, PreschoolFemaleHIV-1HIV InfectionsHumansInfantMaleYoung AdultAnti-HIV Agents

Identifiers

PMID29272387
PMCPMC5961296
OpenAlexW2777700130

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.